Stay updated on Low Dose Sulindac & Eflornithine for FAP Clinical Trial
Sign up to get notified when there's something new on the Low Dose Sulindac & Eflornithine for FAP Clinical Trial page.

Latest updates to the Low Dose Sulindac & Eflornithine for FAP Clinical Trial page
- Check6 days agoChange DetectedVersion tag updated from v3.6.0 to v3.6.2 on the page, signaling an update to the page template or backend. No substantive content edits are shown in the provided changes.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedNew study-record help sections were added: How to Read a Study Record, Common Questions, How to Join a Study, and a standardized Intervention/Treatment label. The old label Intervention / Treatment and the earlier Revision: v3.5.5 note were removed, and the revision line now shows Revision: v3.6.0.SummaryDifference0.9%

- Check27 days agoChange DetectedThe page revision label was updated from v3.5.4 to v3.5.5, indicating a minor backend or formatting update to the page. No study content, eligibility criteria, or results appear to be altered by this revision.SummaryDifference0.1%

- Check49 days agoChange DetectedRevision updated from v3.5.3 to v3.5.4 for the study page. This reflects an administrative update to the ClinicalTrials.gov record rather than a change to the trial itself.SummaryDifference0.1%

- Check64 days agoChange DetectedRevision: v3.5.3 replaces v3.5.2 as the page’s version label, indicating a minor backend/template update. It does not alter the study data, eligibility criteria, outcomes, or other user-visible content.SummaryDifference0.1%

- Check78 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2 on the page.SummaryDifference0.1%

Stay in the know with updates to Low Dose Sulindac & Eflornithine for FAP Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Low Dose Sulindac & Eflornithine for FAP Clinical Trial page.